London Stock Exchange · Healthcare
Invest in Surgical Innovations stock from India
Indian and foreign residents can buy Surgical Innovations (SUN) shares directly through Paasa.
By Paasa · Updated
Surgical Innovations at a glance
- Price
- £0.00+£0.00 (0.00%)
- Market cap
- £3.96M
- Day range
- £0.00 – £0.00
- P/E
- -4.25
- Dividend yield
- None
- Volume
- 975.29K
- 1 month
- +0.00%
- 6 months
- -5.56%
- YTD
- -5.56%
- 1 year
- -34.62%
- 5 years
- -82.65%
Surgical Innovations statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | £11.6M | £11.9M | £12.0M | £11.3M | £9.1M |
| Gross profit | £3.1M | £3.4M | £3.4M | £3.9M | £3.1M |
| Operating income | −£731.0K | −£791.0K | −£596.0K | £41.0K | −£480.0K |
| Net income | −£895.0K | −£1.9M | −£509.0K | £264.0K | −£456.0K |
| Earnings per share | −£0.00 | −£0.00 | −£0.00 | £0.00 | −£0.00 |
| EBITDA | −£73.0K | −£99.0K | £161.0K | £628.0K | £247.0K |
| Total assets | £11.6M | £12.2M | £14.3M | £15.6M | £15.7M |
| Total debt | £665.0K | £1.2M | £1.7M | £2.2M | £2.8M |
| Cash and short-term investments | £813.0K | £195.0K | £1.2M | £2.2M | £3.6M |
| Shareholders' equity | £7.6M | £8.5M | £10.5M | £11.0M | £10.7M |
| Operating cash flow | £569.0K | −£74.0K | £400.0K | £486.0K | −£433.0K |
| Free cash flow | £508.0K | −£409.0K | −£288.0K | −£592.0K | −£1.1M |
| Capital expenditure | −£61.0K | −£335.0K | −£688.0K | −£1.1M | −£657.0K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in GBP; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Genedrive | GDR.L | £0.01 | £1.93B |
| RUA Life Sciences | RUA.L | £0.30 | £1.86B |
| Tissue Regenix | TRX.L | £0.07 | £516.45M |
| MyHealthChecked | MHC.L | £0.09 | £455.31M |
| Proteome Sciences | PRM.L | £0.01 | £404.49M |
| N4 Pharma | N4P.L | £0.00 | £395.33M |
| Cambridge Nutritional Sciences | CNSL.L | £0.02 | £368.82M |
| CRISM Therapeutics | CRTX.L | £0.10 | £365.75M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Surgical Innovations from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to GBP when you buy.
Step 3
Search SUN and buy
Find Surgical Innovations by name or by its ticker, SUN, and place your order.
Why invest in Surgical Innovations from India
What Surgical Innovations does
Established in 1988 and headquartered in Leeds, United Kingdom, Surgical Innovations Group plc is an international enterprise engaged in the design, development, manufacturing, and marketing of devices for minimally invasive surgery (SI) and precision engineering applications. Its global presence extends across the UK, Europe, the Asia Pacific region, and the United States. Surgical Innovations operates in the Medical - Devices industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Here's what inheritance rules in the UK mean for your Surgical Innovations shares.
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.
Frequently asked questions
Can I buy Surgical Innovations stock from India?
Yes. Indian residents and NRIs can buy Surgical Innovations (SUN) shares directly through Paasa. Surgical Innovations is listed on the London Stock Exchange, in the Medical - Devices industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Surgical Innovations dividends taxed for Indian investors?
Surgical Innovations does not currently pay a dividend, so there is nothing to withhold or declare today. If it starts paying one, the UK levies 0% withholding tax on company dividends paid to non-residents, and dividends are taxed at your slab rate in India.
What tax do I pay in India when I sell Surgical Innovations shares?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the GBP/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
What happens to my Surgical Innovations shares if I pass away?
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. The rule looks at everything you hold there, not at Surgical Innovations alone.
Is there stamp duty when I buy Surgical Innovations shares?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.